Condition
Hepato-cellular Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Hepato-cellular Carcinoma clinical trials that are recruiting, at sites in 8 countries (most in France (3), Belgium (2), Germany (2)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 8Countries
Newest Hepato-cellular Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining IV immunotherapy with liver-directed procedures to downstage hepatocellular carcinoma | Phase 2 | Los Angeles, California | Recruiting | Mar 24, 2026 |
| Nerve and heart activity in hepatocellular carcinoma (HCC) | — | Lyon | Recruiting | Feb 6, 2026 |
| LEOPARD: Predicting liver transplant dropout with AI in European patients | — | Ghent, Belgium and 7 other locations | Recruiting | Dec 9, 2024 |
| Collecting data to improve liver transplantation predictions | — | Vienna and 52 other locations | Recruiting | Nov 5, 2024 |
All recruiting trials (4)
-
Combining IV immunotherapy with liver-directed procedures to downstage hepatocellular carcinoma
This tests whether giving IV immunotherapy (tremelimumab plus durvalumab) together with a liver-directed procedure (Y90, TACE, or RFA) can shrink or control hepatocellular carcinoma in adults with intermediate or advanced disease so more people may become eligible for liver transplant.
-
Nerve and heart activity in hepatocellular carcinoma (HCC)
This project will test whether measuring autonomic nervous system signals—such as heart rate patterns, sensory‑response tests, and liver biopsy markers—can help detect or better characterize HCC in adults with compensated cirrhosis who are having a liver biopsy.
-
LEOPARD: Predicting liver transplant dropout with AI in European patients
This project tests new AI-based models to predict which liver transplant candidates are at highest risk of dropout or death while on the waitlist.
-
Collecting data to improve liver transplantation predictions
This study is trying to use AI to better predict which liver transplant candidates are at risk of dropping out of the waitlist, so that more people can get fair access to transplants across Europe.
Related topics
Quick answers
How many Hepato-cellular Carcinoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in France (3 trials), Belgium (2 trials), Germany (2 trials), Italy (2 trials), Netherlands (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.